For academic institutions, biotechnology entities, and analytical laboratories in Nebraska requiring research-grade dinucleotide standards, securing verifiable purity is essential. PX1 Research supplies high-purity lyophilized NAD+ manufactured in the USA, complete with lot-specific Certificate of Analysis documentation. With fast shipping directly from our California and Arizona logistics facilities, Nebraska research entities eliminate international customs friction and receive HPLC/MS-verified reagents.
For academic institutions, biotechnology entities, and analytical laboratories in Nebraska requiring research-grade dinucleotide standards, securing verifiable purity is essential. PX1 Research supplies high-purity lyophilized NAD+ manufactured in the USA, complete with lot-specific Certificate of Analysis documentation. With fast shipping directly from our California and Arizona logistics facilities, Nebraska research entities eliminate international customs friction and receive HPLC/MS-verified reagents.
Laboratory investigations across Nebraska—ranging from agricultural biochemistry models at major state universities to private biomedical research facilities in Omaha and Lincoln—depend on consistent reagent quality. When investigators purchase reagents for enzymatic assays or metabolic pathway evaluations, lot-to-lot variance can introduce unquantifiable noise into experimental models. Sourcing research peptides and dinucleotides from trusted domestic manufacturers ensures that baseline biochemical parameters remain predictable.
PX1 Research synthesizes and processes compounds exclusively within USA-based, GMP-compliant facilities. By adhering to rigorous quality standards, we ensure that researchers in Nebraska receive NAD+ designed specifically for rigorous in vitro and preclinical testing protocols. Each batch undergoes multi-step verification to validate identity, purity percentage, and residual solvent limits before release.
Logistical delays and international customs holds present significant challenges for research schedules. Ordering critical cellular reagents from overseas vendors introduces risks of temperature degradation, delayed delivery, and clearance rejections at ports of entry. PX1 Research solves these supply chain vulnerabilities by dispatching all orders directly from our dual fulfillment centers in California and Arizona.
Orders placed before our daily cutoff time ship same-day (Monday through Friday). Because shipments originate within the continental United States, Nebraska facilities receive express delivery via standard domestic carrier routes without customs documentation or import duties. This localized distribution network guarantees that sensitive research compounds like NAD+ arrive quickly and uncompromised.
Nicotinamide Adenine Dinucleotide (NAD+) is an essential coenzyme found in every living cell, existing in both oxidized (NAD+) and reduced (NADH) forms. Structurally composed of two nucleotides joined through their phosphate groups—one containing an adenine base and the other nicotinamide—it serves as a primary electron carrier in cellular respiration and enzymatic oxidation-reduction reactions.
In preclinical model systems, NAD+ acts as a critical cofactor for sirtuins (SIRT1–SIRT7), poly(ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases (CD38/CD157). Through these interactions, the molecule plays a central role in regulating mitochondrial bioenergetics, oxidative stress responses, and nuclear chromatin remodeling. Understanding these enzymatic cascades requires pristine reference reagents that preserve native binding affinity during in vitro assays.
In vitro data indicate that intracellular NAD+ availability drops significantly during cellular stress, metabolic challenge, and senescent shifts. Consequently, preclinical research models frequently evaluate exogenous NAD+ administration or precursor supplementation to observe changes in mitochondrial respiration rates, oxygen consumption rates (OCR), and extracellular acidification rates (ECAR).
Additionally, rodent models investigating neurodegenerative phenotypes, metabolic dysregulation, and cellular longevity utilize high-purity NAD+ to probe the kinetics of PARP-mediated DNA repair pathways. Because experimental outcomes hinge on reagent concentration accuracy, researchers must rely on compounds that strictly match reported molecular weights and purity specifications.
Quality assurance at PX1 Research extends beyond standard internal testing. Every lot of our research compounds undergoes comprehensive third-party testing at an independent ISO 17025 accredited laboratory. High-Performance Liquid Chromatography (HPLC) is conducted to verify chemical purity, establishing that each batch meets or exceeds our stringent 98%+ threshold.
To confirm exact molecular mass and eliminate potential structural isomers, Mass Spectrometry (MS) analysis is performed concurrently. Furthermore, because bacterial endotoxins can confound cell culture assays and immunological readout models, our catalog undergoes chromogenic LAL endotoxin testing. Every customer in Nebraska can view or download these lot-specific Certificates of Analysis directly from our platform prior to conducting their assays.
When designing cellular metabolism experiments, principal investigators often compare NAD+ against its synthetic and biological precursors or complementary mitochondrial targets. For instance, NMN represents a direct mononucleotide precursor studied for its transport mechanisms via specific membrane transporters, whereas NAD+ is routinely utilized in direct enzymatic binding and cell-free assay systems.
To explore wider mitochondrial pathways, laboratories often cross-reference dinucleotide studies with peptide-based mitochondrial targets like MotS-c or cardiolipin-targeted peptides such as SS-31. While MotS-c focuses on nuclear-mitochondrial communication during metabolic stress, SS-31 specifically restores mitochondrial inner membrane cristae structure. Utilizing fully verified reference standards across these related classes enables comparative study designs.
NAD+ is supplied as a sterile, lyophilized cake or powder to maximize solid-state stability during transport. For optimal preservation, unopened vials should be stored at -20°C in a dry, dark environment upon arrival at your Nebraska laboratory facility.
When preparing solutions for in vitro assays, researchers should reconstitute the powder using sterile, nuclease-free water or an appropriate buffered solution (such as PBS, pH 7.4). Because NAD+ in aqueous solution is susceptible to hydrolysis over time, reconstituted aliquots should be used immediately or sub-aliquoted and stored at -80°C to avoid repeated freeze-thaw cycles that can degrade the compound.
PX1 Research supports the procurement needs of high-volume research projects, multi-lab departments, and commercial assay developers throughout Nebraska. Our institutional team streamlines purchasing processes by accepting formal purchase orders, providing vendor onboarding documentation, and coordinating custom batch sizes.
Through our dedicated wholesale program, research facilities gain access to tiered volume pricing, dedicated account management, and reserved lot allocation. This ensures that long-term longitudinal studies maintain consistent lot numbers throughout the entire trial duration, preventing batch-effect variability across experimental cohorts.
How quickly will an NAD+ order arrive at my laboratory in Nebraska?
Orders placed before our daily cutoff time ship same-day (Monday through Friday) from our fulfillment centers in California and Arizona. Standard domestic priority transit times to Nebraska addresses typically range between 2 to 3 business days, completely avoiding international customs delays.
Are PX1 Research compounds intended for clinical or therapeutic use?
No. All products supplied by PX1 Research, including NAD+, are strictly for in vitro, cell culture, and laboratory research use only. They are not intended for human or animal therapeutic use, clinical administration, or medical diagnosis.
How is the purity of PX1 NAD+ verified?
Every lot undergoes independent third-party analysis at an ISO 17025 accredited laboratory. Purity is validated using High-Performance Liquid Chromatography (HPLC), identity is confirmed via Mass Spectrometry (MS), and endotoxin levels are measured via LAL testing.
Where can I access the Certificate of Analysis (COA) for my shipment?
Lot-specific COAs are published directly on our website and accessible via the product page or by contacting support with your lot number. Every shipment matches the analytical report generated for that specific batch.
What solvent should be used to reconstitute NAD+ for laboratory assays?
NAD+ is readily soluble in sterile, nuclease-free water or standard physiological buffers such as Phosphate-Buffered Saline (PBS). Researchers should choose solvents compatible with their specific in vitro assay parameters.
What are the recommended long-term storage conditions for lyophilized NAD+?
Unopened, lyophilized NAD+ should be stored at -20°C in a desiccated environment protected from direct light. After reconstitution, aqueous solutions should be sub-aliquoted and stored at -80°C to prevent degradation from freeze-thaw cycles.
Does PX1 Research offer bulk purchasing for Nebraska research entities?
Yes. Academic departments, private biotechnology firms, and contract research organizations (CROs) in Nebraska can register for a wholesale account via our site to receive volume discounts and reserved lot allocations.
How does NAD+ differ structurally from precursor molecules like NMN in research settings?
NAD+ is a complete dinucleotide composed of nicotinamide and adenine linked by a phosphate bridge. NMN (Nicotinamide Mononucleotide) is a single nucleotide precursor containing only the nicotinamide base attached to a ribose and single phosphate group, requiring enzymatic conversion via NMNAT to form NAD+.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.